• Vision & goals
• Research
• Production
• Organization
• Management
• Department Directors
• Board of directors
• History

About Oasmia

Oasmia Pharmaceutical AB develops a new generation of drugs within human and veterinary oncology. The product development aims to manufacture novel formulations based on well-established cytostatics which, in comparison with current alternatives, show improved properties, a reduced side-effect profile and an expanded therapeutic area. The product development is based on in-house research within nanotechnology and company patents.

In addition to strategic investments in oncology we also have a number of promising patents and candidates in therapy fields such as infection, asthma and neurology.